Lee's Pharm Signs China Deal for Two BioQuiddity Infusion Products

Lee's Pharmaceutical signed a strategic license to register and market in China two single dose infusion products from BioQuiddity of San Francisco: ropivacaine, a local anesthetic, and propofol, an anesthetic-sedative. BioQuiddity makes one-dose, ready-to-use infusion products. Eddingpharm will have rights to the drugs in mainland China, Taiwan, Hong Kong, and Macau. Financial details were not disclosed. More details.... Stock Symbol: (HK: 0950) Share this with colleagues: // //